Trial
NCT04770701
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Trieu, Nguyen Thi, M.D.
Collaborators
—
Condition
HIV-1-infection
Intervention
Ahah Drug
Why stopped
The study was withdrawn before enrollment due to administrative and board approval constraints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04